Kyle Bettinger

Title: Innovations by Inventor Kyle Bettinger

Introduction

Kyle Bettinger is an accomplished inventor based in Blaine, MN (US). He holds a total of 4 patents that showcase his contributions to the field of biomedical engineering. His work primarily focuses on developing advanced solutions for wound treatment.

Latest Patents

One of Bettinger's latest patents is a biologic matrix for a wound site and related methods. This biologic matrix comprises a three-dimensional, resorbable collagen scaffold derived from a vascularized portion of a perfusion-decellularized, suspension-dried mammalian organ or tissue. The scaffold features a porous structure with a plurality of interconnected pores originating from one or more of its outer surfaces. The pores are created by forcing a gas through the vascular pathways of the mammalian organ or tissue while it is in a suspended position. This innovative approach enables the gas to inflate the vascular pathways in all directions without restriction. The porous configuration substantially enhances the scaffold's effective surface area, making it at least 10 times greater than that of a non-porous scaffold having equivalent outer dimensions. In certain embodiments, the surface area considering the interconnected pores can be 15 times larger or more than the non-porous scaffold of equivalent outer dimensions.

Another significant patent involves a method for augmenting a void or treating a wound in a body cavity. This method entails applying a three-dimensional, resorbable collagen scaffold derived from a vascularized portion of a perfusion-decellularized mammalian tissue or organ to the site of the void or body cavity. The scaffold can be applied in a manner that ensures at least three surfaces or five surfaces come into contact with the surrounding body tissue. The scaffold contains numerous pores, resulting in a larger surface area compared to a scaffold without pores of the same outer dimensions. Additionally, the method includes releasing an antimicrobial agent into the surrounding body tissue to inhibit infection. The antimicrobial agent, such as silver nanoparticles, methylene blue, or iodine-based compounds, is perfused into the scaffold's vascular pathways following its perfusion decellularization.

Career Highlights

Kyle Bettinger is currently associated with Reprise Biomedical, Inc., where he continues to innovate in the field of biomedical solutions. His work has significantly impacted the development of advanced wound care technologies.

Collaborations

One of his notable coworkers is Jason Isenburg, who collaborates with him